Browsing: elelyso

(Português) Protalix vê as vendas de medicamentos para tratamento da doença de Gaucher subirem.

Sorry, this entry is only available in Português.


Read More
Protalix signs $280m Brazilian Gaucher deal

Pfizer will waive its commercialization rights on the seven year deal for Gaucher treatment Uplyso for $12.5 million annually. Protalix Biotherapeutics Inc. (AMEX:PLX; TASE: PLX) announced today that it has entered into a supply and technology


Read More